# Lattice-Based Radiotherapy and Chemoimmunotherapy for Oropharyngeal Squamous Cell Carcinoma

> **NCT07428148** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **NYU Langone Health** · enrollment: 60 (estimated)

## Conditions studied

- Oropharyngeal Squamous Cell Carcinoma

## Interventions

- **DRUG:** Induction Chemo-Immunotherapy
- **RADIATION:** Lattice Radiotherapy

## Key facts

- **NCT ID:** NCT07428148
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05
- **Primary completion:** 2031-05
- **Final completion:** 2033-05
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07428148

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07428148, "Lattice-Based Radiotherapy and Chemoimmunotherapy for Oropharyngeal Squamous Cell Carcinoma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07428148. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*